Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement.
Juan Salvador García-MaturanoDavid Eduardo Torres-OrdazMiguel Mosqueda-GutiérrezCitlallyc J Gómez-RuizAarón Vázquez-MelladoAlicia Tafoya AmadoIngris Pelaez-BallestasRubén Burgos VargasJanitzia Vazquez-MelladoPublished in: Clinical rheumatology (2021)
In gout patients, flares were 9 times more frequent during pandemic also, they had increased urate levels but led to an unexpected improvement in HAQ and functionality scores. Resilience and lifestyle changes in gout during COVID-19 pandemic require further studies. Key Points • COVID-19 pandemic is associated with 4 times more flares in gout patients. • Increased flares were also seen in previously well-controlled gout patients. • Increased serum urate levels were also found in gout patients during pandemic. • In our gout clinic, 8/101 patients were diagnosed as COVID-19+, and two of them died.
Keyphrases
- sars cov
- end stage renal disease
- chronic kidney disease
- ejection fraction
- newly diagnosed
- coronavirus disease
- prognostic factors
- peritoneal dialysis
- primary care
- cardiovascular disease
- physical activity
- climate change
- patient reported outcomes
- depressive symptoms
- weight loss
- respiratory syndrome coronavirus
- case control